NVDA

175.79

+0.74%↑

AVGO.US

313.58

+1.32%↑

ORCL

145.31

-0.97%↓

MU

368.06

+9%↑

CSCO

77.98

+0.45%↑

NVDA

175.79

+0.74%↑

AVGO.US

313.58

+1.32%↑

ORCL

145.31

-0.97%↓

MU

368.06

+9%↑

CSCO

77.98

+0.45%↑

NVDA

175.79

+0.74%↑

AVGO.US

313.58

+1.32%↑

ORCL

145.31

-0.97%↓

MU

368.06

+9%↑

CSCO

77.98

+0.45%↑

NVDA

175.79

+0.74%↑

AVGO.US

313.58

+1.32%↑

ORCL

145.31

-0.97%↓

MU

368.06

+9%↑

CSCO

77.98

+0.45%↑

NVDA

175.79

+0.74%↑

AVGO.US

313.58

+1.32%↑

ORCL

145.31

-0.97%↓

MU

368.06

+9%↑

CSCO

77.98

+0.45%↑

Search

MKS Inc

Abierto

SectorTecnología

236.47 4.13

Resumen

Variación precio

24h

Actual

Mínimo

228.12

Máximo

239.64

Métricas clave

By Trading Economics

Ingresos

34M

108M

Ventas

45M

1B

P/B

Media del Sector

53.78

81.314

BPA

2.47

Rentabilidad por dividendo

0.39

Margen de beneficios

10.455

Empleados

10,200

EBITDA

3M

226M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+24.81% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

0.39%

2.43%

Próximas Ganancias

6 may 2026

Fecha Próximo Dividendo

5 jun 2026

Próxima Fecha de Ex Dividendo

26 may 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-1.7B

16B

Apertura anterior

232.34

Cierre anterior

236.47

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

157 / 375 Clasificación en Technology

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

MKS Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

31 mar 2026, 23:31 UTC

Acciones populares

Stocks to Watch: Nike, RH, NCino

31 mar 2026, 22:35 UTC

Ganancias

Nike Guides for Sales Declines Ahead as Turnaround Plan Hits Snags -- 2nd Update

1 abr 2026, 00:00 UTC

Adquisiciones, fusiones, absorciones

The Year Is Off to the Strongest Start for Big Deals Ever -- WSJ

31 mar 2026, 23:50 UTC

Adquisiciones, fusiones, absorciones

Nxera Pharma: Partner Centessa Pharmaceuticals to Be Acquired by Lilly >LLY 4565.TO

31 mar 2026, 23:43 UTC

Charlas de Mercado

Nikkei May Rise on Hopes for Iran War Ending Soon -- Market Talk

31 mar 2026, 23:33 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Gold Edges Higher on Signs of De-Escalating Middle East Tensions -- Market Talk

31 mar 2026, 23:21 UTC

Ganancias

Nike Stock Slides on Tariff Impact Despite Earnings Beat; Turnaround Continues -- Barrons.com

31 mar 2026, 23:14 UTC

Charlas de Mercado
Ganancias

Nike CEO Says Turnaround is Taking Longer Than He'd Like -- Market Talk

31 mar 2026, 23:12 UTC

Charlas de Mercado

Aurelia's Cash Flow Strength Highlighted by New Financing Deal -- Market Talk

31 mar 2026, 22:36 UTC

Ganancias

China Vanke 2025 Loss Widens >000002.SZ

31 mar 2026, 22:36 UTC

Ganancias

China Vanke: Increase in Inventory Impariment Provision Among Factors Weighing On Results>000002.SZ

31 mar 2026, 22:36 UTC

Ganancias

China Vanke 2025 Loss CNY88.56B Vs. Loss CNY49.48B >000002.SZ

31 mar 2026, 22:36 UTC

Ganancias

China Vanke: Will Take Time to Resolve Issues Caused by High Debt Levels>000002.SZ

31 mar 2026, 22:36 UTC

Ganancias

China Vanke 2025 Rev CNY233.43B Vs. CNY343.18B >000002.SZ

31 mar 2026, 21:46 UTC

Adquisiciones, fusiones, absorciones

Big Drug Companies Hunting for Deals Are Lowering Their Sights -- WSJ

31 mar 2026, 21:36 UTC

Charlas de Mercado

West African Resources's Costs Higher Than Bull Expected -- Market Talk

31 mar 2026, 21:35 UTC

Ganancias

Nike Expects China Sales Down 20% in 4Q, CFO Says

31 mar 2026, 21:35 UTC

Ganancias

Nike Expects Modest Growth in North America, Offset by Declines in China, Converse Brand in 4Q, CFO Says

31 mar 2026, 21:35 UTC

Ganancias

Nike Forecasts 4Q Sales Down 2% to 4%, CFO Says

31 mar 2026, 21:33 UTC

Adquisiciones, fusiones, absorciones

Biotechs Are a Healthy Growth Bet Thanks to M&A and New Drugs -- Barrons.com

31 mar 2026, 21:33 UTC

Ganancias

Nike Expects Sales Down Low-Single Digits From Now Through End of Calendar Year, CFO Says

31 mar 2026, 21:32 UTC

Ganancias

Nike Expects 1Q to Be Final Quarter Where Tariffs Continue to Be Year-Over-Year Headwind to Margins, CFO Says

31 mar 2026, 21:28 UTC

Ganancias

Nike Expects to End 4Q With Elevated Inventory, CFO Says

31 mar 2026, 21:26 UTC

Ganancias

Nike Increasingly Confident It Will Return to Balanced Growth in North America in Direct, Wholesale Channels, CFO Says

31 mar 2026, 21:25 UTC

Ganancias

Nike Expects Supply-Chain Changes to Pay Off Starting in Fiscal 2027, CFO Says

31 mar 2026, 21:24 UTC

Charlas de Mercado
Ganancias

Nike: Turnaround Plan Progressing at Different Rates -- Market Talk

31 mar 2026, 21:22 UTC

Ganancias

Nike CFO Expects Football Training and Basketball Will Return to Growth Over Next Few Quarters

31 mar 2026, 21:22 UTC

Ganancias

Nike's Sportswear Business Declined Low-Double Digits in 3Q, CFO Says

31 mar 2026, 21:21 UTC

Ganancias

Nike's Digital Channel Still Too Promotional, CFO Says

31 mar 2026, 21:20 UTC

Ganancias

Nike CEO: Converse Remains Important to Portfolio

Comparación entre iguales

Cambio de precio

MKS Inc previsión

Precio Objetivo

By TipRanks

24.81% repunte

Estimación a 12 Meses

Media 286.82 USD  24.81%

Máximo 320 USD

Mínimo 200 USD

De acuerdo con 11 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para MKS Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

11 ratings

9

Comprar

1

Mantener

1

Vender

Puntuación técnica

By Trading Central

74.13 / 77.31Soporte y Resistencia

Corto Plazo

Bullish Evidence

Medio plazo

Bullish Evidence

Largo Plazo

Strong Bearish Evidence

Sentimiento

By Acuity

157 / 375 Clasificación en Tecnología

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de MKS Inc

MKS Instruments, Inc. provides foundational technology solutions to semiconductor manufacturing, electronics and packaging, and specialty industrial applications in the United States, Germany, China, South Korea, and internationally. It operates through Vacuum Solutions Division (VSD), Photonics Solutions Division (PSD), and Material Solutions Division (MSD) segments. The VSD segment provides foundational technology solutions, including pressure measurement and control, flow measurement and control, gas and vapor delivery, gas composition analysis, electronic control technology, reactive gas generation and delivery, power generation and delivery, and vacuum technology. The PSD segment offers range of solutions, which include lasers, beam measurement and profiling, precision motion control, vibration isolation systems, photonics instruments, temperature sensing, opto-mechanical components, optical elements, systems for flexible PCB laser processing, and laser-based systems, as well as high density interconnect PCB and package manufacturing. The MSD segment develops, process, and manufactures technologies comprising advanced surface modification, electroless and electrolytic plating, and surface finishing for chemistry, equipment, software, and services markets, as well as high-technology applications. In addition, the company sells its products and services through direct sales, network of independent distributors, and sales representatives, as well as websites, including product catalogs. The company was incorporated in 1961 and is headquartered in Andover, Massachusetts.
help-icon Live chat